Effects of fasudil in acute ischemic stroke: Results of a prospective placebo-controlled double-blind trial

Journal of the Neurological Sciences

Volumn 238, Issue 1-2, 2005, Pages 31-39

  Shibuya, Masato ^a   Hirai, Shunsaku ^b   Seto, Minoru ^c   Satoh, Shin Ichi ^c   Ohtomo, Eiichi ^d  

^a CHUKYO HOSPITAL   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c ASAHI KASEI PHARMA CORPORATION   (Japan)

^d Yokufukai Geriatric Hospital   (Japan)

Author keywords

Acute ischemic stroke; Clinical trial; Fasudil; Rho kinase

Indexed keywords

FASUDIL; PLACEBO;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ANEMIA; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMMON COLD; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; HYPERGLYCEMIA; INSOMNIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; NEUROLOGIC EXAMINATION; OCCULT BLOOD; PATIENT SELECTION; PRIORITY JOURNAL; TREATMENT OUTCOME; URINARY TRACT INFECTION;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ACUTE DISEASE; AGED; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PROSPECTIVE STUDIES; PROTEIN-SERINE-THREONINE KINASES; VASODILATOR AGENTS;

EID: 27644505297     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2005.06.003     Document Type: Article

References (31)

1. J. Yrjanheikki, T. Tikka, R. Keinanen, G. Goldsteins, P.H. Chan, and J. Koistinaho A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window Proc Natl Acad Sci U S A 96 1999 13496 13500
2. M. Shibuya, Y. Suzuki, K. Sugita, I. Saito, T. Sasaki, and K. Takakura Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage J Neurosurg 76 1992 571 577
3. S.P. Davies, H. Reddy, M. Caivano, and P. Cohen Specificity and mechanism of action of some commonly used protein kinase inhibitors Biochem J 351 2000 95 105
4. 2α-induced contraction of rabbit aortae J Physiol 546 2003 823 836
5. K. Miyata, H. Shimokawa, T. Kandabashi, T. Higo, K. Morishige, and Y. Eto Rho-kinase is involved in macrophage-mediated formation of coronary vascular lesions in pigs in vivo Arterioscler Thromb Vasc Biol 20 2000 2351 2358
6. H. Shimokawa Cellular and molecular mechanisms of coronary artery spasm Jpn Circ J 64 2000 1 12
7. M. Sato, E. Tani, H. Fujikawa, and K. Kaibuchi Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm Circ Res 87 2000 195 200
8. A. Masumoto, Y. Hirooka, H. Shimokawa, K. Hironaga, S. Setoguchi, and A. Takeshita Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans Hypertension 38 2001 1307 1310
9. M. Takemoto, J. Sun, J. Hiroki, H. Shimokawa, and J.K. Liao Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase Circulation 106 2002 57 62
10. V. Niggli Rho-kinase in human neutrophils: a role in signalling for myosin light chain phosphorylation and cell migration FEBS Lett 445 1999 69 72
11. S. Chrissobolis, and C.G. Sobey Evidence that Rho-kinase activity contributes to cerebral vascular tone in vivo and is enhanced during chronic hypertension Circ Res 88 2001 774 779
12. A. Kawaguchi, M. Ohmori, K. Harada, S. Tsuruoka, K. Sugimoto, and A. Fujimura The effect of a Rho kinase inhibitor Y-27632 on superoxide production, aggregation and adhesion in human polymorphonuclear leukocytes Eur J Pharmacol 403 2000 203 208
13. R.A. Worthylake, S. Lemoine, J.M. Watson, and K. Burridge RhoA is required for monocyte tail retraction during transendothelial migration J Cell Biol 154 2001 147 160
14. 2+ sensitization in the bovine cerebral artery Circ Res 91 2002 112 119
15. S. Satoh, I. Ikegaki, Y. Suzuki, T. Asano, M. Shibuya, and H. Hidaka Neuroprotective properties of a protein kinase inhibitor against ischaemia-induced neuronal damage in rats and gerbils Br J Pharmacol 118 1996 1592 1596
16. S. Satoh, T. Utsunomiya, K. Tsurui, T. Kobayashi, I. Ikegaki, and Y. Sasaki Pharmacological profile of hydroxyl fasudil as a selective rho kinase inhibitor on ischemic brain damage Life Sci 69 2001 1441 1453
17. Y. Toshima, S. Satoh, I. Ikegaki, and T. Asano A new model of cerebral microthrombosis in rats and the neuroprotective effect of a Rho-kinase inhibitor Stroke 31 2000 2245 2250
18. S. Satoh, T. Kobayashi, A. Hitomi, I. Ikegaki, Y. Suzuki, and M. Shibuya Inhibition of neutrophil migration by a protein kinase inhibitor for the treatment of ischemic brain infarction Jpn J Pharmacol 80 1999 41 48
19. S. Satoh, T. Yamaguchi, A. Hitomi, N. Sato, K. Shiraiwa, and I. Ikegaki Fasudil attenuates interstitial fibrosis in rat kidneys with unilateral ureteral obstruction Eur J Pharmacol 455 2002 169 174
20. M. Arai, Y. Sasaki, and R. Nozawa Inhibition by the protein kinase inhibitor HA1077 of the activation of NADPH oxidase in human neutrophils Biochem Pharmacol 46 1993 1487 1490
21. M. Higashi, H. Shimokawa, T. Hattori, J. Hiroki, Y. Mukai, and K. Morikawa Long-term inhibition of Rho-kinase suppresses Angiotensin II-induced cardiovascular hypertrophy in rats in vivo Circ Res 93 2003 767 775
22. M. Tsuchiya, K. Sako, Y. Yonemasu, and T. Asano The effects of HA1077, a novel protein kinase inhibitor, on reductions of cerebral blood flow and glucose metabolism following acute and/or chronic bilateral carotid artery ligation in Wistar rats Exp Brain Res 97 1993 233 238
23. K. Nagata, Y. Kondoh, Y. Satoh, Y. Watahiki, E. Yokoyama, and H. Yuya Effects of fasudil hydrochloride on cerebral blood flow in patients with chronic cerebral infarction Clin Neuropharmacol 16 1993 501 510
24. A. Hitomi, S. Satoh, I. Ikegaki, Y. Suzuki, M. Shibuya, and T. Asano Hemorheological abnormalities in experimental cerebral ischemia and effects of protein kinase inhibitor on blood fluidity Life Sci 67 2000 1929 1939
25. F. Gotoh, Y. Terayama, and T. Amano Development of a novel, weighted, quantifiable stroke scale Stroke 32 2001 1800 1807
26. N. Watari, and L.Z. Benet Determination of mean input time, mean residence time, and steady-state volume of distribution with multiple drug inputs J Pharmacokinet Biopharm 17 1989 593 599
27. S.E. Akopov, N.A. Simonian, and G.S. Grigorian Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage Stroke 27 1996 1739 1743
28. C. Iadecola Bright and dark sides of nitric oxide in ischemic brain injury Trends Neurosci 20 1997 132 139
29. Z. Szikszai, I. Fekete, and S.G. Imre A comparative study of hemorheological parameters in transient ischemic attack and acute ischemic stroke patients: possible predictive value Clin Hemorheol Microcirc 28 2003 51 57
30. G.H. Danton, and W.D. Dietrich Inflammatory mechanisms after ischemia and stroke J Neuropathol Exp Neurol 62 2003 127 136
31. K.R. Lees, H.-C. Diener, K. Asplund, and M. Krams UK-279,276, a neutrophil inhibitory glycoprotein, in acute stroke Stroke 34 2003 1704 1709